OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Role of Progesterone Receptors in Breast Cancer
Zhuo Li, Hongrui Wei, Siyan Li, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 305-314
Open Access | Times Cited: 125
Zhuo Li, Hongrui Wei, Siyan Li, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 305-314
Open Access | Times Cited: 125
Showing 1-25 of 125 citing articles:
Biomarkers in Breast Cancer: An Old Story with a New End
Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1364-1364
Open Access | Times Cited: 50
Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1364-1364
Open Access | Times Cited: 50
From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression
Riya Thapa, Obaid Afzal, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154959-154959
Closed Access | Times Cited: 49
Riya Thapa, Obaid Afzal, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154959-154959
Closed Access | Times Cited: 49
Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice
Laura López-González, Alicia Sánchez Cendra, Cristina Sánchez Cendra, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 168-168
Open Access | Times Cited: 17
Laura López-González, Alicia Sánchez Cendra, Cristina Sánchez Cendra, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 168-168
Open Access | Times Cited: 17
Unveiling the Role of Hormonal Imbalance in Breast Cancer Development: A Comprehensive Review
Shweta Satpathi, Sagar S Gaurkar, Ashwini Potdukhe, et al.
Cureus (2023)
Open Access | Times Cited: 27
Shweta Satpathi, Sagar S Gaurkar, Ashwini Potdukhe, et al.
Cureus (2023)
Open Access | Times Cited: 27
Receptor-Targeted Nanomedicine for Cancer Therapy
Arvee Prajapati, Shagun Rangra, Rashmi Patil, et al.
Receptors (2024) Vol. 3, Iss. 3, pp. 323-361
Open Access | Times Cited: 12
Arvee Prajapati, Shagun Rangra, Rashmi Patil, et al.
Receptors (2024) Vol. 3, Iss. 3, pp. 323-361
Open Access | Times Cited: 12
Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy
Lu-Qi Cao, Haidong Sun, Yuhao Xie, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Lu-Qi Cao, Haidong Sun, Yuhao Xie, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research
B Witt, Trygve O. Tollefsbol
Life (2023) Vol. 13, Iss. 12, pp. 2311-2311
Open Access | Times Cited: 17
B Witt, Trygve O. Tollefsbol
Life (2023) Vol. 13, Iss. 12, pp. 2311-2311
Open Access | Times Cited: 17
lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer
Asif Ahmad Bhat, Muhammad Afzal, Ehssan Moglad, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Asif Ahmad Bhat, Muhammad Afzal, Ehssan Moglad, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
The clinical value of progesterone receptor expression in luminal breast cancer: A study of a large cohort with long‐term follow‐up
Ayat G. Lashen, Michael S. Toss, Nigel P. Mongan, et al.
Cancer (2023) Vol. 129, Iss. 8, pp. 1183-1194
Open Access | Times Cited: 13
Ayat G. Lashen, Michael S. Toss, Nigel P. Mongan, et al.
Cancer (2023) Vol. 129, Iss. 8, pp. 1183-1194
Open Access | Times Cited: 13
Toxicity overview of endocrine disrupting chemicals interacting in vitro with the oestrogen receptor
Raúl Alva-Gallegos, Alejandro Carazo, Přemysl Mladěnka
Environmental Toxicology and Pharmacology (2023) Vol. 99, pp. 104089-104089
Closed Access | Times Cited: 13
Raúl Alva-Gallegos, Alejandro Carazo, Přemysl Mladěnka
Environmental Toxicology and Pharmacology (2023) Vol. 99, pp. 104089-104089
Closed Access | Times Cited: 13
Association of Proteasome Activity and Pool Heterogeneity with Markers Determining the Molecular Subtypes of Breast Cancer
И. В. Кондакова, E. E. Sereda, E. A. Sidenko, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 159-159
Open Access
И. В. Кондакова, E. E. Sereda, E. A. Sidenko, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 159-159
Open Access
Synthesis, Molecular Modeling, Cytotoxicity, and Apoptosis-Inducing Activity of Some Novel 4,6-Dihydroisothiochromeno[4,3-B]Pyran Derivatives as Potent Anticancer and Tubulin-Inhibiting Agents
Salehe Sabouri, Fatemeh Haghani, Mohammad Amin Langarizadeh, et al.
(2025)
Closed Access
Salehe Sabouri, Fatemeh Haghani, Mohammad Amin Langarizadeh, et al.
(2025)
Closed Access
Roles of Post-Translational Modifications of Transcription Factors Involved in Breast Cancer Hypoxia
Logan Seymour, Niyogushima Nuru, Kaya R. Johnson, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 645-645
Open Access
Logan Seymour, Niyogushima Nuru, Kaya R. Johnson, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 645-645
Open Access
The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors
Murad Guliyev, Ali Kaan Güren, Emre Özge, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 693-693
Open Access
Murad Guliyev, Ali Kaan Güren, Emre Özge, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 693-693
Open Access
Senna petersiana (Bolle) leaf alkaloid-rich extracts exert cytotoxic and photodynamic activities in MCF-7 breast cancer cells
Kolawole A. Olofinsan, Blassan P. George
South African Journal of Botany (2025) Vol. 180, pp. 315-324
Open Access
Kolawole A. Olofinsan, Blassan P. George
South African Journal of Botany (2025) Vol. 180, pp. 315-324
Open Access
CXCR4/CXCL12 blockade therapy; a new horizon in TNBC therapy
Abdulrahman Qais Khaleel, Farag M. A. Altalbawy, Majid S. Jabir, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Abdulrahman Qais Khaleel, Farag M. A. Altalbawy, Majid S. Jabir, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Exploring Novel Therapeutic Targets in Breast Cancer via Comprehensive Omics Profiling and Experimental Verification
Shengjun Chai, Jisheng Cui, Yinuo Sun, et al.
Biology (2025) Vol. 14, Iss. 4, pp. 405-405
Open Access
Shengjun Chai, Jisheng Cui, Yinuo Sun, et al.
Biology (2025) Vol. 14, Iss. 4, pp. 405-405
Open Access
An in vitro investigation of the apoptosis-inducing activity of corosolic acid in breast cancer cells.
Saade Abdalkareem Jasim, Omer Zedan Khalaf, Shadia Hamoud Alshahrani, et al.
PubMed (2023) Vol. 26, Iss. 4, pp. 453-460
Closed Access | Times Cited: 11
Saade Abdalkareem Jasim, Omer Zedan Khalaf, Shadia Hamoud Alshahrani, et al.
PubMed (2023) Vol. 26, Iss. 4, pp. 453-460
Closed Access | Times Cited: 11
Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy
Lin Jia, Junning Peng, Nan Sun, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Lin Jia, Junning Peng, Nan Sun, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
In silico evaluation of potential breast cancer receptor antagonists from GC-MS and HPLC identified compounds in Pleurotus ostreatus extracts
Magdalene Eno Effiong, Mercy Bella-Omunagbe, Israel Sunmola Afolabi, et al.
RSC Advances (2024) Vol. 14, Iss. 33, pp. 23744-23771
Open Access | Times Cited: 4
Magdalene Eno Effiong, Mercy Bella-Omunagbe, Israel Sunmola Afolabi, et al.
RSC Advances (2024) Vol. 14, Iss. 33, pp. 23744-23771
Open Access | Times Cited: 4
From diagnosis to therapy: The role of LncRNA GAS5 in combatting some cancers affecting women
Chou‐Yi Hsu, Safia Obaidur Rab, Ahmed Hussein Zwamel, et al.
Gene (2025), pp. 149217-149217
Closed Access
Chou‐Yi Hsu, Safia Obaidur Rab, Ahmed Hussein Zwamel, et al.
Gene (2025), pp. 149217-149217
Closed Access
Identification of Novel Progesterone Receptor (PR) Inhibitors (Homo sapiens) from Metabolites of Biotransformation Fungal: A Bioinformatics Approach
Janaína de Araújo E. Dourado, Samuel Q. Lopes, David Esteban Quintero Jimenez, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 136-136
Open Access
Janaína de Araújo E. Dourado, Samuel Q. Lopes, David Esteban Quintero Jimenez, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 136-136
Open Access
Extracting Knowledge from Machine Learning Models to Diagnose Breast Cancer
José Manuel Martínez-Ramírez, C. J. Carmona, Marı́a Jesús Ramı́rez-Expósito, et al.
Life (2025) Vol. 15, Iss. 2, pp. 211-211
Open Access
José Manuel Martínez-Ramírez, C. J. Carmona, Marı́a Jesús Ramı́rez-Expósito, et al.
Life (2025) Vol. 15, Iss. 2, pp. 211-211
Open Access
Comprehensive Analysis of Six Biomarkers Expression in Early-stage Breast Cancer: A Cross-sectional Study
Hamid K. Al-Tameemi, Dina A.A. Abdullah, Mustafa T. Albaldawy, et al.
Dubai Medical Journal (2025) Vol. 8, Iss. 1, pp. 57-72
Open Access
Hamid K. Al-Tameemi, Dina A.A. Abdullah, Mustafa T. Albaldawy, et al.
Dubai Medical Journal (2025) Vol. 8, Iss. 1, pp. 57-72
Open Access
Recent advancements and future applications of intrauterine drug delivery systems
Ashwin Abhang, Diane J. Burgess
Expert Opinion on Drug Delivery (2025)
Closed Access
Ashwin Abhang, Diane J. Burgess
Expert Opinion on Drug Delivery (2025)
Closed Access
